Dow Down0.62% Nasdaq Down1.14%

Myriad Genetics Inc. (MYGN)

-NasdaqGS
37.97 Up 0.46(1.23%) 4:00PM EDT
|After Hours : 37.51 Down 0.46 (1.21%) 4:21PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 188,766   182,923   204,060   202,467  
Cost of Revenue30,980  26,609  26,131  25,481  
Gross Profit 157,786   156,314   177,929   176,986  
Operating Expenses
Research Development20,187  13,396  17,090  16,803  
Selling General and Administrative84,345  87,633  77,840  77,279  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 53,254   55,285   82,999   82,904  
Income from Continuing Operations
Total Other Income/Expenses Net(701)2,056  1,145  923  
Earnings Before Interest And Taxes52,553  57,341  84,144  83,827  
Interest Expense -   -   -   -  
Income Before Tax52,553  57,341  84,144  83,827  
Income Tax Expense18,921  20,573  33,784  28,362  
Minority Interest -   -   -   -  
Net Income From Continuing Ops33,632  36,768  50,360  55,465  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 33,632   36,768   50,360   55,465  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 33,632   36,768   50,360   55,465  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.